Retraction: Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis.

Retraction: Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis.

Bibliographic Details
Main Author:	PLOS ONE Editors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6795435?pdf=render

Similar Items

Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis.
by: Chiara Corrado, et al.
Published: (2012-01-01)

Carboxyamidotriazole-orotate inhibits the proliferation and mitochondrial energy metabolism of mouse glioma cell line GL261
by: HUANG Yu-qing, GAO Hong-ting, YANG Li-xing, CHEN Qiu-xia, WANG Yu-cheng, JU Rui, GUO Lei
Published: (2021-07-01)

Carboxyamidotriazole-orotate inhibits proliferation and mitochondrial metabolism in human pancreatic cancer gemcitabine-resistant cell strain
by: CHEN Qiu-xia, YANG Li-xing, MA Rui, ZHAO Yong-jing, WANG Yu-cheng, JU Rui, GUO Lei
Published: (2022-04-01)

Effects of carboxyamidotriazole-orotate on oncogenic phenotypes of mouse glioma-associated macrophage cell lines
by: MA Rui, YANG Li-xing, CHEN Qiu-xia, QIU Jia-xing, WANG Yu-cheng, JU Rui, GUO Lei
Published: (2022-05-01)

Retraction: Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.
by: PLOS ONE Editors
Published: (2024-01-01)

Retraction: Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor Growth, Angiogenesis, Invasion, and Metastasis.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth.
by: PLOS ONE Editors
Published: (2019-01-01)

Rotating between ponatinib and imatinib temporarily increases the efficacy of imatinib as shown in a chronic myeloid leukaemia model
by: H. Jonathan G. Lindström, et al.
Published: (2022-03-01)

Retraction: Hypothalamic Inhibition of Acetyl-CoA Carboxylase Stimulates Hepatic Counter-Regulatory Response Independent of AMPK Activation in Rats.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis.
by: PLOS ONE Editors
Published: (2022-01-01)

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
by: Haneen Banjar, et al.
Published: (2017-01-01)

Retraction: Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages.
by: PLOS ONE Editors
Published: (2014-01-01)

Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib
by: Gian Paolo Bombeccari, et al.
Published: (2017-12-01)

Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation
by: E Loveman, et al.
Published: (2012-05-01)

Retraction: uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Use of Granulocyte Colony-Stimulating Factor for the Treatment of Thin Endometrium in Experimental Rats.
by: PLOS ONE Editors
Published: (2020-01-01)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet.
by: PLOS ONE Editors
Published: (2022-01-01)

Feasibility of treatment-free remission with generic imatinib: Results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase study
by: Deepak Goni, et al.
Published: (2023-01-01)

An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia
by: Bee, P.C., et al.
Published: (2012)

Retraction: Nicotinamide Inhibits Alkylating Agent-Induced Apoptotic Neurodegeneration in the Developing Rat Brain.
by: PLOS ONE Editors
Published: (2024-01-01)

Retraction: MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Modulation of the Pentose Phosphate Pathway Induces Endodermal Differentiation in Embryonic Stem Cells.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction.
by: PLOS ONE Editors
Published: (2018-01-01)

Stimulation of the immune system by liposomes with potassium orotate (review)
by: V. V. Mosyagin
Published: (2023-08-01)

An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia
by: Lisa Repsold, et al.
Published: (2017-10-01)

Retraction: Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: MicroRNA-153 Inhibits Osteosarcoma Cells Proliferation and Invasion by Targeting TGF-β2.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: Inhibition of Spontaneous Recovery of Fear by mGluR5 after Prolonged Extinction Training.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Silicon fertilization counteracts salinity-induced damages associated with changes in physio-biochemical modulations in spinach.
by: PLOS ONE Editors
Published: (2022-01-01)

Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
by: G Rogers, et al.
Published: (2012-04-01)

Retraction: Arnica montana Stimulates Extracellular Matrix Gene Expression in a Macrophage Cell Line Differentiated to Wound-Healing Phenotype.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Analysis of the Prevalence, Secretion and Function of a Cell Cycle-Inhibiting Factor in the Melioidosis Pathogen Burkholderia pseudomallei.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
by: PLOS ONE Editors
Published: (2022-01-01)